Pharmacyclics, Inc. (PCYC) Posts Q2 Loss of 26c/Share
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
CGEH, NAKA, APOG, More
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $113 million versus the consensus estimate of $95.88 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Mount Logan Capital to join Russell Microcap Index on June 29
- Travel + Leisure (TNL) Reiterated at Buy by Stifel: 'There is Upside to the Multiple'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
